Issue |
Title |
Vol 23, No 1 (2019) |
INFORMATION ABOUT SCIENTIFIC STUDDING LEVEL ON PROBLEM OF HYPERTENSION-MEDIATED ORGAN DAMAGE IN MONGOLIA |
|
Maksikova T.M., Barsuren T., Kalyagin A.N., Babanskaya E.B. |
Vol 21, No 4 (2017) |
SPECIFIC FEATURES OF THE HEMODYNAMIC, RHEOLOGICAL AND BIOENERGETIC INDICATORS IN WEATHER-SENSITIVE PATIENTS WITH THE ARTERIAL HYPERTENSION |
|
Zhukov A.G., Mikhailova E.V., Muratov S.V., Karpenko V.Y. |
Vol 21, No 2 (2017) |
MODERN CONCEPTS OF SYSTEMIC ARTERIAL HYPERTENSION AS COMPLICATION OF BRONCHOPULMONARY DYSPLASIA |
|
Ovsyannikov D.Y., Strutynskaya A.D., Kantemirova M.G., Karnaushkina M.A. |
No 3 (2010) |
Of antiagregational activity of the vessel wall in patients with arterial hypertension and metabolic syndrome, who suffered from occlusion of eye vessels |
|
Medvedev I.N., Danilenko O.A. |
No 1 (2010) |
Itravascular activity of trombocytes in arterial hypertension patients with dislipidemia on a background fluvastatine |
|
Medvedev I.N., Skorjatina I.A. |
No 4 (2013) |
Aggregation of neutrophils in patients with arterial hypertension dyslipidemic patients receiving rosuvastatin |
|
Skoryatina I.A., Medvedev I.N. |
No 4 (2009) |
Genes of vascular reactions and formation of the arterial hypertension at chronic glomerulonephritis |
|
Litovkina O.N., Nekipelova E.V., Proshchaev K.I., Aristova I.K., Nesterov V.G., Churnosov M.I. |
No 1 (2012) |
Erythrocytes' rheological properties in patients with arterial hypertension and dyslipidemia against simvastatin therapy |
|
Medvedev I.N., Skoryatina I.A. |
No 3 (2011) |
Microalbuminuria in risk stratification of non-diabetic hypertesive patients |
|
Villevalde S.V., Tuykhmenev E.A., Klimenko A.S., Pigareva Y.A., Kobalava Z.D. |
No 4 (2009) |
Preliminary data of an investigations of the influence weather factors on hemodynamics in patients with arterial hypertension and ischmic heart disease in traditional therapy and complex therapy with melaxen |
|
Zaslavskaya R.M., Shcherban E.A., Logvinenko S.I., Tejbloom M.M. |
No 2 (2011) |
On rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemia |
|
Medvedev I.N., Skorjatina I.А. |
No 2 (2012) |
The polymorphism c677t of the gene MTHFR correlates with the complications of the coronary heart disease and arterial hypertension for the patients with dislipidaemia |
|
Myandina G.I., Kasapova E.N., Zotova T.U., Frolov V.A. |
No 4 (2012) |
Antiaggregant impact of vascular wall on hemocyte in hypertension patients with dyslipidemia taking simvastatin |
|
Skoryatina I.A., Medvedev I.N. |
No 2 (2014) |
Renin profile in patients with untreated hypertension and its association with arterial stiffness parameters |
|
Kravtsova O.A., Kotovskaya Y.V., Kobalava Z.D. |
No 4 (2010) |
Clinical efficiency of medium and high doses of valsartan in the treatment of patient with arterial hypertension and chronic kidney diseases |
|
Maximov M.L., Dralova O.V. |
No 4 (2011) |
CASPASE-3 and CASPASE-8 activity in right ventricular myocardial cells in experimental arterial hypertension |
|
Azova M.M., Blagonravov M.L., Frolov V.A. |
No 4 (2010) |
Clinical application of direct renin inhibitor aliskiren in combined therapy of patients with arterial hypertension and metabolic syndrome |
|
Dralova O.V., Maximov M.L., Ermolaeva A.S. |
No 3 (2010) |
Influence of adaptogens on hemodynamic disturbances in meteosensivity of patients with arterial hypertension and ischemic heart disease |
|
Zaslavskaya R.M., Shcherban E.A., Logvinenko S.I. |
No 4 (2010) |
Тhe possibilities of complex correction of antiagregational activity of the vessel wall in patients with arterial hypertension and metabolic syndrome, who suffered from the occlusion of eye vessels |
|
Danilenko O.A., Medvedev I.N. |
No 3 (2010) |
Angiotensin II receptor antagonist valsartan in treatment of patients with arterial hypertension and chronic kidney diseases. Hypotensive and nephroprotective efficacy |
|
Maximov M.L., Dralova O.V. |
1 - 20 of 20 Items |
|